Cytogen Corporation - SWOT Analysis
Datamonitor's Cytogen Corporation - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Cytogen is a specialty pharmaceutical company focused on building, developing, and commercializing a portfolio of oncology products for the treatment and care of cancer patients. The company currently markets Quadramet (samarium Sm-153 lexidronam injection), Prostascint (capromab pendetide), and Soltamox (tamoxifen citrate) to the US oncology market. Cytogen is headquartered in Princeton, New Jersey and employed 95 people as of December 2006. The company recorded revenues of $17 million during the fiscal year ended December 2006, an increase of 8.8% over 2005. The operating loss of the company was $30 million during fiscal year 2006, as compared to $29 million in 2005. The net loss in fiscal year 2006 was $29 million, as compared to $28 million in 2005.
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
RELATED REPORTS
Impact of Pharmacogenomics on Public Healthcare PolicyImmense advances in genetic code decipherment over the last decade have recently led to personalized medicine, or ‘the right drug for the right person’, becoming an achievable concept. Pharmacogenomics (PGx) embodies the principles of persona ...
Industries : Pharmaceutical | Countries : USA, Japan
IntroductionBone metastases are a complication of some advanced cancers including cancers of the breast, lung, prostate, kidney and thyroid. The incidence of bone metastases across these tumor types in the seven major markets is forecasted to total 225,174 in 2008. While treatment with bisphosphonat ...
Industries : Pharmaceutical | Countries : USA
IntroductionToday, pharma companies face growing competition from generics and me-too drugs, combined with increasingly tough P&R, a clamp down on healthcare spending, and the need to treat patients for longer due to the aging population. These factors threaten both current and future revenues promp ...
Industries : Pharmaceutical | Countries : USA, China, Japan, India, Spain, France, United Kingdom
IntroductionSLE is a chronic, life-long and potentially fatal autoimmune disease characterized by multiple system distress and unpredictable flares. Therapy is largely off-label and a huge demand exists for new SLE therapies because of the potential for serious side effects from drugs currently used ...
Industries : Pharmaceutical | Countries : Mexico, Canada, USA, China, Japan, India, Croatia, Germany, Spain, France, Italy, United Kingdom
IntroductionIdeally drug supply should be a simple and transparent chain that connects the manufacturer and patient in as few steps as possible, however in practice it can be a highly circuitous one that includes several intermediaries before reaching a pharmacy. This increases the risk of counterfe ...
Industries : Pharmaceutical | Countries : USA, United Kingdom
Datamonitor's Merck & Co., Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. M ...
Industries : Pharmaceutical | Countries : USA
Datamonitor's Shire plc - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Shire Pha ...
Industries : Pharmaceutical | Countries : USA, United Kingdom
Datamonitor's Endo Pharmaceuticals Holdings Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue line ...
Industries : Pharmaceutical | Countries : USA
Datamonitor's Cardinal Health, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strateg ...
Industries : Pharmaceutical | Countries : USA
Datamonitor's ISTA Pharmaceuticals, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and st ...
Industries : Pharmaceutical | Countries : USA
Related industries
reportlinker.com © Copyright 2009. All rights reserved